TrialNeuro-oncology2017

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.

Michael Wahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.